Browse resources

Total results with these characteristics: 1524

Diseases and the Vaccines That Prevent Them

This series of fact sheets describes symptoms of infection as well as the benefits and risk of vaccination for 14 diseases, including hepatitis B, Haemophilus influenzae type b, influenza, pneumococcal disease, polio, and rotavirus. There …

Author: US Centers for Disease Control and Prevention

Published: 2011

Disposable-Syringe Jet Injectors

Jet injectors deliver vaccines and medicines without using needles. PATH has worked with several disposable-syringe jet injector developers to advance designs that are suitable and affordable for routine and campaign immunization programs in …

Author: PATH

Published: 2014

Disposal and Destruction of Syringes and Needles in Vietnam and the Philippines

The paper reports on a field trial of disposal and destruction methods (including autocombustion incinerators) in the two countries.

Author: World Health Organization

Published: 1998

Dissociation Between Serum Neutralizing and Glycoprotein Antibody Responses of Infants and Children Who Received Inactivated Respiratory Syncytial Virus Vaccine

In the 1960s a respiratory syncytial virus (RSV) vaccine was evaluated in infants and young children. Vaccinees who received formalin-inactivated RSV during early infancy developed more serious lower-respiratory-tract disease when infected with the …

Author: Murphy BR, Prince GA, Walsh EE, et al.

Published: 1986

Distribution of Rotavirus Genotypes in Europe, 2004-2005: The REVEAL Study

Rotavirus genotypes were identified in several European countries using ELISA tests, and investigators determined that G1–G4 and G9 genotypes were responsible for the majority of cases. Citing these results, the authors suggest that rotavirus …

Author: Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M

Published: 2007

Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness

This article, published in Vaccine, reports on an analysis that combines the results of a country-level model of rotavirus vaccination published elsewhere with data from Demographic and Health Surveys on within-country patterns of vaccine coverage …

Author: Rheingans R, Atherly D, Anderson J

Published: 2012

DNA Vaccine Delivery by Densely-Packed and Short Microprojection Arrays to Skin Protects Against Vaginal HSV-2 Challenge

This article, published in Vaccine, reports on a study that investigates the tolerability, immunogenicity, and efficacy of a plasmid DNA vaccine encoding the extracellular domain of gD2 using the Nanopatch™, a recently devised silicon …

Author: Kask AS, Chen X, Marshak JO, et al.

Published: 2010

DNA Vaccines Expressing Pneumococcal Surface Protein A (PspA) Elicit Protection Levels Comparable to Recombinant Protein

This article, published in the Journal of Medical Microbiology, provide results that show that DNA vaccines expressing PspA are able to elicit protection levels comparable to recombinant protein, even though total anti-PspA IgG response is …

Author: Ferreira DM, Miyaji EN, Oliveira MLS, et al.

Published: 2006

DOD and PATH: Collaborations Enhance Health for the World's Poorest People

This fact sheet describes how PATH and the US Department of Defense (DOD) collaborate to enhance the health of the world’s poorest people and presents a sampling of PATH projects, including work on vaccines to prevent diarrhea and vaccine …

Author: PATH

Published: 2012

Domestic Refrigerators for Vaccine Storage in Tunisia: Conclusion and Recommendations

This project Optimize document summarizes a laboratory report on performance testing of four models of domestic refrigerators that are available on the Tunisian market. Project Optimize contracted the tests to demonstrate to the government the …

Author: PATH, World Health Organization

Published: 2012

A Dose-Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial

This study, published in the Journal of Infectious Diseases, tested the neonatal rotavirus candidate vaccine 116E in a double-blind, placebo-controlled dose-escalation trial in India. Two doses of the Vero cell-adapted vaccine were evaluated in …

Author: Bhandari N, Sharma P, Taneja S, et al.

Published: 2009

Duration of Protection of Pentavalent Rotavirus Vaccination in Nicaragua

This article, published in Pediatrics, summarizes a case-control study conducted at four hospitals in Nicaragua to evaluate the duration of protection after rotavirus vaccination among eligible infants. The pentavalent rotavirus vaccine …

Author: Patel M, Pedreira C, De Oliveira LH, et al.

Published: 2012

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

The authors of this article, published in The American Journal of Epidemiology, use data on immunization with serogroup C meningococcal conjugate vaccines in England and Wales to develop and apply a mathematical model that investigates the …

Author: Trotter CL, Gay NJ, Edmunds WJ

Published: 2005

Early Thimerosal Exposure and Neuropsychological Outcome at 7 and 10 Years

Investigators assessed neurological outcomes by testing more than 1,000 children aged 7 to 10 years and determined that early exposure to mercury from thimerosal-containing vaccines was not associated with deficits in neuropsychological functioning. …

Author: Thompson W, Price C, Goodson B, et al.

Published: 2007

Economic Costs of Rotavirus Gastroenteritis and Cost-Effectiveness of Vaccination in Developing Countries

This article, published in The Journal of Infectious Diseases, evaluated the economic burden of rotavirus and the cost-effectiveness of vaccination from the health care perspective. The authors found that rotavirus vaccination would annually prevent …

Author: Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD

Published: 2009

Economic Evaluation of Delivering Haemophilus influenzae type b Vaccine in Routine Immunization Services in Kenya

This study, published in Bulletin of the World Health Organization, discusses the introduction of Hib vaccine in Kenya, one of the first nine countries to receive financial support from GAVI for Hib vaccine introduction. The objective of this study …

Author: Oloo Akumu A, Englisha M, Scott JAG, Griffiths UK

Published: 2007

Economic Evaluation of Haemophilus influenzae type b Vaccination in Indonesia: A Cost-Effectiveness Analysis

This paper, published in the Journal of Public Health, evaluates the cost-effectiveness of introducing Hib vaccine in Indonesia as an addition to the country's current DTP–Hepatitis B vaccination program.

Author: Broughton E

Published: 2007

Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009

This article, published in Pediatrics, presents an economic analysis of the US childhood immunization schedule. The study used population-based vaccination coverage, vaccine efficacy data, historical data on disease incidence before vaccination, and …

Author: Zhou F, Shefer A, Wenger J, et al.

Published: 2014

An Economic Evaluation of Thermostable Vaccines in Cambodia, Ghana, and Bangladesh

This article, published in Vaccine, evaluates the incremental health and programmatic cost impacts of theoretical new vaccine products as compared to the standard vaccine products in multi-dose vials in Cambodia, Ghana, and Bangladesh. The authors …

Author: Levin A, Levin C, Kristensen D, Matthias D

Published: 2007

Economic Evaluations of Rotavirus Immunization for Developing Countries: A Review of the Literature

This article, published in Expert Review of Vaccines, analyzes the cost-effectiveness of universal rotavirus immunization in developing countries. The authors identified and evaluated 15 cost-effectiveness studies conducted in the developing world. …

Author: Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ

Published: 2011

Economic Impact of a Rotavirus Vaccination Program in Mexico

This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …

Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y

Published: 2009

Economics of Immunization: A Guide to the Literature and Other Resources

This 87-page document identifies literature and web resources on costing, cost-benefit analyses, financing, and policy among other issues.

Author: World Health Organization, US Agency for International Development, and Partners in Health Reform Plus

Published: 2004

Edward Jenner and the Discovery of Vaccination

This online exhibition showcases rare books and historical documents dealing with immunization, with a focus on Edward Jenner's role in the discovery of vaccination. His research was based on careful case studies and clinical observation more than a …

Author: Thomas Cooper Library, University of South Carolina

Published: 1996

Effect of a Conjugate Pneumococcal Vaccine on the Occurrence of Respiratory Infections and Antibiotic Use in Day-Care Center Attendees

Published in the Pediatric Infectious Disease Journal, this article examines whether the use of a pneumococcal conjugate vaccine could reduce the occurrence of respiratory infections and the ensuing antibiotic drug use in the day care. In this …

Author: Dagan R, Sikuler-Cohen M, Zamir O, et al.

Published: 2001

Effect of a Serogroup A Meningococcal Conjugate Vaccine (PsA—TT) on Serogroup A Meningococcal Meningitis and Carriage in Chad: A Community Study

A serogroup A meningococcal polysaccharide—tetanus toxoid conjugate vaccine (PsA—TT, MenAfriVac) was licensed in India in 2009, and prequalified by the World Health Organization in 2010, on the basis of its safety and immunogenicity. This …

Author: Daugla DM, Gami JP, Gamougam K, et al.

Published: 2013